PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Gliclazide
Presentation Product Chemical substance Chapter Items dispensed
Gliclazide 80mg tablets
0601021M0AAAAAA
Gliclazide Gliclazide Endocrine System 389,504
Gliclazide 40mg tablets
0601021M0AAARAR
Gliclazide Gliclazide Endocrine System 235,741
Gliclazide 30mg modified-release tablets
0601021M0AAAMAM
Gliclazide Gliclazide Endocrine System 84,055
Gliclazide 60mg modified-release tablets
0601021M0AAATAT
Gliclazide Gliclazide Endocrine System 29,158
Gliclazide 160mg tablets
0601021M0AAAVAV
Gliclazide Gliclazide Endocrine System 9,790
Gliclazide 80mg/5ml oral suspension
0601021M0AAASAS
Gliclazide Gliclazide Endocrine System 307
Gliclazide 40mg/5ml oral suspension
0601021M0AAAUAU
Gliclazide Gliclazide Endocrine System 171
Gliclazide 100mg/5ml oral suspension
0601021M0AAALAL
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 120mg/5ml oral suspension
0601021M0AAAIAI
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 160mg/5ml oral suspension
0601021M0AAAJAJ
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 20mg/5ml oral suspension
0601021M0AAANAN
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 30mg/5ml oral suspension
0601021M0AAAPAP
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 50mg/5ml oral suspension
0601021M0AAAHAH
Gliclazide Gliclazide Endocrine System No data available
Gliclazide 60mg/5ml oral suspension
0601021M0AAAGAG
Gliclazide Gliclazide Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.